H.I.G. Capital Recapitalizes Navitas Life Sciences

H.I.G. Capital Acquires Taconic Biosciences

February 7, 2019

Healthcare Services

H.I.G. Capital, through an affiliate, has completed the acquisition of Taconic Biosciences, a global provider of genetically engineered research models and related services. The private equity investment will partner with Taconic's management to support geographic expansion, broaden product and service offerings, and accelerate M&A-driven growth.

H.I.G. Capital Completes Recapitalization of Health Network One

October 7, 2021

Healthcare Services

H.I.G. Capital completed a recapitalization of Health Network One, a Ft. Lauderdale-based provider of specialty benefit management and provider network services for health insurers. The investment will support platform investment, capability enhancement, and accelerated growth organically and through M&A.

H.I.G. Capital Recapitalizes Health Network One

June 30, 2021

Healthcare Services

H.I.G. Capital completed a recapitalization of Health Network One (HNO), a Fort Lauderdale-based operator of single-specialty provider networks. Financial terms were not disclosed; the recapitalization is intended to provide HNO with additional resources to support growth and continued network expansion.

H.I.G. Capital Acquires Majority Stake in Life Agro

November 5, 2024

Agriculture

H.I.G. Capital, through an affiliate, acquired a majority stake in Life Agro, a Brazil-based producer of specialty agricultural inputs. Life Agro’s founder and CEO Matias Ezequiel Tiecher remains a significant shareholder and will continue as CEO; the company (~200 employees) operates two production facilities and eight distribution centers and has grown ~45% CAGR over the past five years.

Laird Superfood Completes Acquisition of Navitas LLC

January 5, 2026

Consumer Products

Laird Superfood, Inc. completed its previously announced acquisition of all outstanding equity of Navitas LLC for $38.5 million in cash. The deal was funded alongside a concurrent $50.0 million investment of Series A Convertible Preferred Stock to affiliates of Nexus Capital Management, LP.

Avista Capital Partners Acquires Taconic Biosciences

November 1, 2022

Biotechnology

Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Taconic, a Rensselaer, New York–based provider of genetically engineered murine research models and related preclinical services, will leverage Avista's healthcare investing expertise to pursue organic growth and strategic acquisitions in the GEMs market.